DK257389D0 - Human cellelinie af epithel lungeadenocarcinom oprindelse, humane proteiner og fremgangsmaade til fremstilling deraf - Google Patents

Human cellelinie af epithel lungeadenocarcinom oprindelse, humane proteiner og fremgangsmaade til fremstilling deraf

Info

Publication number
DK257389D0
DK257389D0 DK257389A DK257389A DK257389D0 DK 257389 D0 DK257389 D0 DK 257389D0 DK 257389 A DK257389 A DK 257389A DK 257389 A DK257389 A DK 257389A DK 257389 D0 DK257389 D0 DK 257389D0
Authority
DK
Denmark
Prior art keywords
human
lungeadenocarcinom
epithel
origin
producing
Prior art date
Application number
DK257389A
Other languages
Danish (da)
English (en)
Other versions
DK257389A (da
Inventor
Jeffrey A Whitsett
Adi F Gazdar
Original Assignee
Childrens Hosp Medical Center
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center, Us Commerce filed Critical Childrens Hosp Medical Center
Publication of DK257389D0 publication Critical patent/DK257389D0/da
Publication of DK257389A publication Critical patent/DK257389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK257389A 1987-09-28 1989-05-26 Human cellelinie af epithel lungeadenocarcinom oprindelse, humane proteiner og fremgangsmaade til fremstilling deraf DK257389A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10157287A 1987-09-28 1987-09-28
PCT/US1988/003342 WO1989002915A1 (en) 1987-09-28 1988-09-28 Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods

Publications (2)

Publication Number Publication Date
DK257389D0 true DK257389D0 (da) 1989-05-26
DK257389A DK257389A (da) 1989-05-26

Family

ID=22285359

Family Applications (1)

Application Number Title Priority Date Filing Date
DK257389A DK257389A (da) 1987-09-28 1989-05-26 Human cellelinie af epithel lungeadenocarcinom oprindelse, humane proteiner og fremgangsmaade til fremstilling deraf

Country Status (5)

Country Link
EP (1) EP0313224A1 (de)
JP (1) JPH02424A (de)
DK (1) DK257389A (de)
WO (1) WO1989002915A1 (de)
ZA (1) ZA887282B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4713824B2 (ja) * 2003-11-17 2011-06-29 Ｇｋｎドライブラインジャパン株式会社 駆動力伝達装置の潤滑構造
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9598462B2 (en) 2012-01-26 2017-03-21 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
JP4851404B2 (ja) * 2006-11-10 2012-01-11 Ｇｋｎドライブラインジャパン株式会社 動力伝達装置
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
WO2009029686A1 (en) 2007-08-27 2009-03-05 Longhorn Vaccines & Diagnostics Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CA2861667C (en) * 2007-10-01 2017-06-13 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system and methods of use
AU2013202291B2 (en) * 2007-10-01 2013-11-14 Longhorn Vaccines & Diagnostics, Llc Biological specimen collection/transport compositions and methods
CN105567639A (zh) * 2014-10-13 2016-05-11 上海市肿瘤研究所 人肺腺癌细胞lc-21细胞及用途
US9976136B2 (en) 2015-05-14 2018-05-22 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002037A1 (en) * 1985-09-26 1987-04-09 Genetics Institute, Inc. Pulmonary surfactant proteins

Also Published As

Publication number Publication date
JPH02424A (ja) 1990-01-05
DK257389A (da) 1989-05-26
ZA887282B (en) 1990-01-31
WO1989002915A1 (en) 1989-04-06
EP0313224A1 (de) 1989-04-26

Similar Documents

Publication Publication Date Title
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK662887D0 (da) Fladeformigt terapeutisk system, fremgangsmaade til fremstilling deraf og anvendelse deraf
DK597288D0 (da) Rekombinant, humant immunoglobulin og fremgangsmaade til fremstilling deraf
DK9197A (da) Vaccine baseret på membranbundne proteiner og fremgangsmåde til fremstilling deraf
DK571389D0 (da) Fremgangsmaade og middel til nedsaettelse af postkirurgisk adhaesion
DK285488D0 (da) Peptid, praeparat indeholdende peptidet og proevemetode, hvor peptidet anvendes
DK664887A (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK257389D0 (da) Human cellelinie af epithel lungeadenocarcinom oprindelse, humane proteiner og fremgangsmaade til fremstilling deraf
DK179187D0 (da) Apparat og fremgangsmaade til hoestning af afgroeder
DK360788A (da) Fremgangsmaade til fremstilling af ordnede kollagenstrukturer, isaer af human oprindelse, og de fremstillede, ordnede kollagenstrukturer
DK223089D0 (da) Lysdaemper og fremgangsmaade til fremstilling deraf
DK398987D0 (da) Fremgangsmaade til fremstilling af blodprotein
DK96394A (da) 5-Halogenalkylidinimono-1-arylpyrazoler og fremgangsmåde til fremstilling deraf
DK567688D0 (da) Fremgangsmaade og apparat til stoerrelsessortering af levende fisk
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK241790D0 (da) Fremgangsmaade til fremstilling af sucralfat og aai-10001
DK221389D0 (da) Fibronectin-bindende protein og fremgangsmaade til fremstilling deraf
DK39689A (da) Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre og n-phosphonmethyliminodieddikesyrechlorid
DK67786A (da) Fremgangsmaade til fremstilling af arylglycidylethere og 3-substituerede 1-alkylamino-2-propanoler
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK378488A (da) Anellerede iminoazoler og iminoaziner, fremgangsmaade til fremstilling heraf og deres anvendelse med herbicid virkning
DK712488D0 (da) Oploeselig, rekombinant fcepsilon-receptor og fremgangsmaade til fremstilling heraf
DK54590D0 (da) Fremgangsmaade til modifikation og reduktion af kulaske
DK485988A (da) Bovint placentrat lactogen og fremgangsmaade til fremstilling deraf
NO910090D0 (no) Vevstransplantat-sammensetning og metode.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment